Seres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
07 Septiembre 2023 - 9:00AM
Business Wire
Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome
therapeutics company, today announced that Seres management will
participate at the Morgan Stanley 21st Annual Global Healthcare
Conference on Monday, September 11, 2023, at 12:15 p.m. ET.
An audio webcast of the presentation will be available under the
“Investors and News” section of Seres’ website. A replay of the
presentation will become available approximately one hour after the
event and will be archived for 21 days.
About Seres Therapeutics
Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage
company developing novel microbiome therapeutics for serious
diseases. In June 2023, Seres was named one of the TIME100 Most
Influential Companies. Seres’ lead program, VOWST™, obtained U.S.
FDA approval in April 2023 as the first orally administered
microbiome therapeutic to prevent recurrence of C. difficile
infection (CDI) in adults following antibacterial treatment for
recurrent CDI and is being commercialized in collaboration with
Nestlé Health Science. Seres is evaluating SER-155 in a Phase 1b
study in patients receiving allogeneic hematopoietic stem cell
transplantation. The Company is also conducting research to inform
further development of microbiome therapeutics for ulcerative
colitis. For more information, please visit
www.serestherapeutics.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230907084202/en/
Investor and Media Contacts: Kevin Mannix
kmannix@serestherapeutics.com Carlo Tanzi, Ph.D.
ctanzi@serestherapeutics.com
Seres Therapeutics (NASDAQ:MCRB)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Seres Therapeutics (NASDAQ:MCRB)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024